TOKYO -- An advisory panel to Japan's health minister decided Friday to allow public health insurance coverage for a gene therapy for muscular dystrophy beginning February 20 and set the drug's official price at about 304.97 million yen.
Editor-in-Chief: LE THE CHU
Publication permit 1332/BTTTT-PTTH&TTĐT, granted by the Ministry of Information and Communications of
the Socialist Republic of Vietnam
Advertise with Us | Contact Us
Hotline: 0918.033.133
© All rights are reserved by Tuoi Tre/Tuoi Tre News. Content may not be republished, except with the prior written permission of Tuoi Tre/Tuoi Tre News.
Please enter Display Name
Please enter Email
Email Invalid Format
Please enter Email
Email Invalid Format
Incorrect password.
Incorrect login information.
Account locked, please contact administrator.
An error occurred. Please try again later.
